Published in
American Association for the Advancement of Science, Science Translational Medicine, 484(11), 2019
DOI: 10.1126/scitranslmed.aav0891
Links
Tools
Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer
Journal article published in 2019 by
Loredana Puca 
,
Katie Gavyert ,
Verena Sailer,
Vincenza Conteduca ,
Etienne Dardenne,
Michael Sigouros ,
Kumiko Isse,
Megan Kearney ,
Aram Vosoughi ,
Luisa Fernandez,
Heng Pan ,
Samaneh Motanagh,
Judy Hess,
Adam J. Donoghue ,
Andrea Sboner
and other authors.
,
Katie Gavyert ,
Verena Sailer,
Vincenza Conteduca ,
Etienne Dardenne,
Michael Sigouros ,
Kumiko Isse,
Megan Kearney ,
Aram Vosoughi ,
Luisa Fernandez,
Heng Pan ,
Samaneh Motanagh,
Judy Hess,
Adam J. Donoghue ,
Andrea Sboner
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
DLL3 is overexpressed in neuroendocrine prostate cancer and is a potential therapeutic target.